Glaucoma warning
Use caution if you have glaucoma or increased eye pressure.
Medicine information ENERZAIR BREEZHALER 114mcg / 46mcg / 136mcg inhalation powder, capsules
- Product code:
- W66830005
- Quantity:
- 150
- Indicated for:
- asthma
- Route of administration:
- inhalation
- Substance:
- indacaterol + glycopyrronium bromide + mometasone (beta-2 adrenergic agonist+bronchodilator+glucocorticoid)
- ATC
- R03AL12 — Respiratory system | Adrenergics, inhalants | Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids
The combination of indacaterol, glycopyrronium bromide, and mometasone is used for the treatment of chronic obstructive pulmonary disease (COPD) and severe asthma. Indacaterol is a long-acting beta-2 adrenergic agonist, glycopyrronium is an anticholinergic, and mometasone is a corticosteroid that reduces inflammation.
The medication is administered via inhalation, usually once daily, as directed by a doctor. It is important to follow the treatment regimen to achieve the best results.
Side effects may include cough, dry mouth, headache, or throat irritation. In rare cases, severe allergic reactions or paradoxical bronchospasm may occur.
This combination is not recommended for patients with hypersensitivity to any of the components or severe cardiac conditions.
The medication is administered via inhalation, usually once daily, as directed by a doctor. It is important to follow the treatment regimen to achieve the best results.
Side effects may include cough, dry mouth, headache, or throat irritation. In rare cases, severe allergic reactions or paradoxical bronchospasm may occur.
This combination is not recommended for patients with hypersensitivity to any of the components or severe cardiac conditions.
General data about ENERZAIR BREEZHALER 114mcg / 46mcg / 136mcg
- Substance:
- indacaterol + glycopyrronium bromide + mometasone
- Date of latest medicines list:
- 01-10-2020
- Product code:
- W66830005
- Strength:
- 114mcg / 46mcg / 136mcg
- Pharmaceutical form:
- inhalation powder, capsules
- Quantity:
- 150
- Product type:
- Original
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Strengths available for indacaterol + glycopyrronium bromide + mometasone
- 114mcg+46mcg+136mcg
- 114mcg/46mcg/136mcg
Official documents
The SmPC text is not displayed because a match to this medicine, strength and pharmaceutical form has not been confirmed.
The correspondence between the document and the displayed text is unconfirmed.
- Source institution
- EMA
- Document language
- English
- Source record: first published
- 21/07/2020
- Source record: last updated
- 20/11/2025
Warnings:
Anticholinergic effects
May cause dry mouth, constipation, urinary retention, or blurred vision.
Hyperglycemia
This medicine may increase blood sugar.
Immunosuppression / infection risk
This medicine may increase the risk of infections.
Breastfeeding warning
Use during breastfeeding only on medical advice.
Pregnancy warning
Use during pregnancy only on medical advice.
Elderly warning
Older people may have an increased risk of side effects.
Cardiac risk / QT prolongation / arrhythmias
This medicine may increase the risk of heart rhythm disturbances.